News
BSX
51.69
+0.53%
0.27
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
NASDAQ · 15h ago
What's Backing Abbott's Established Pharmaceuticals Division Growth
NASDAQ · 16h ago
Citi Keeps Their Buy Rating on Boston Scientific (BSX)
TipRanks · 18h ago
Boston Scientific’s MANDARIN Trial Shines Spotlight on Liver Cancer Strategy in China
TipRanks · 1d ago
Boston Scientific Chairman Acquires 13% More Stock
Simply Wall St · 1d ago
Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)
TipRanks · 2d ago
Artisan Global Equity Fund Q2 2026 Portfolio Review
Seeking Alpha · 2d ago
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone
Seeking Alpha · 2d ago
Boston Scientific Director Habiger Buys $100k of Shares Amid 54% Decline. What Does This Mean for BSX in 2026?
The Motley Fool · 3d ago
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?
The Motley Fool · 3d ago
How Investors Are Reacting To Boston Scientific (BSX) Recall Wave After Strong Mid‑Year Results
Simply Wall St · 3d ago
Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results
PR Newswire · 3d ago
Weekly Report: what happened at BSX last week (0803-0807)?
Weekly Report · 3d ago
Boston Scientific (BSX) Faces Device Recalls, Is It Still A Bargain?
Simply Wall St · 4d ago
Insider trades: Microsoft, Meta, Pfizer among notable names
Seeking Alpha · 5d ago
Boston Scientific, Circle, Illumina, Southern Co, Toyota Insider Frenzy
TipRanks · 5d ago
Insider Confidence Surge: Boston Scientific Director Makes Bold Stock Move
TipRanks · 6d ago
Boston Scientific (BSX) Q2 2026 Earnings Call Transcript
The Motley Fool · 6d ago
Boston Scientific Corporation (NYSE:BSX) Just Reported, And Analysts Assigned A US$62.69 Price Target
Simply Wall St · 6d ago
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
NASDAQ · 08/06 18:16
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology and vascular therapies (ICVT), watchman, cardiac rhythm management, and electrophysiology.